Rifaximin for the treatment of newly diagnosed Crohn's disease: A case series

被引：0

作者：

Shafran, Ira ^{[1
]}

Burgunder, Patricia ^{[1
]}

机构：

[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：2158 / 2160

页数：3

共 5 条

[1] Antimicrobials in the management of inflammatory bowel disease [J].

Gionchetti, P ;

Rizzello, F ;

Lammers, KM ;

Morselli, C ;

Tambasco, R ;

Campieri, M .

DIGESTION, 2006, 73 :77-85

[2] Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin [J].

Prantera, C ;

Lochs, H ;

Campieri, M ;

Scribano, ML ;

Sturniolo, GC ;

Castiglione, F ;

Cottone, M .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) :1117-1125

[3] A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease [J].

Rahimi, Roja ;

Nikfar, Shekoufeh ;

Rezaie, Ali ;

Abdollahi, Mohammad .

CLINICAL THERAPEUTICS, 2006, 28 (12) :1983-1988

[4] Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics [J].

Sartor, RB .

GASTROENTEROLOGY, 2004, 126 (06) :1620-1633

[5] An open-label evaluation of rifaximin in the treatment of active Crohn's disease [J].

Shafran, I ;

Johnson, LK .

CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) :1165-1169

← 1 →